The Scientific Foundation of Chinese Herbal Medicine against COVID-19

Elaine Lai-Han Leung1, Hu-Dan Pan1, Yu-Feng Huang1

  • 1State Key Laboratory of Quality Research in Chinese Medicine & Macau Institute for Applied Research in Medicine and Health & Faculty of Chinese Medicine, Macau University of Science and Technology, Macao 999078, China.

Engineering (Beijing, China)
|February 1, 2021
PubMed

Insights

Traditional Chinese medicine offers potential therapeutic strategies for coronavirus disease 2019 (COVID-19), drawing from historical applications against similar viral infections. Further research is needed to confirm the efficacy of Chinese herbal formulas (CHFs) in combating COVID-19.

Area of Science:

  • Virology and Immunology
  • Traditional Chinese Medicine
  • Pharmacology

Background:

  • The COVID-19 pandemic presents a global health crisis, with SARS-CoV-2 sharing genomic similarities to SARS-CoV and MERS-CoV.
  • COVID-19 progression involves viral infection, immune suppression, cytokine storm, multi-organ damage, and lung fibrosis.
  • Limited specific treatments necessitate exploring alternative and complementary therapeutic strategies.

Purpose of the Study:

  • To review and summarize the potential uses and therapeutic mechanisms of Chinese herbal formulas (CHFs) for COVID-19.
  • To examine CHFs and patent drugs recommended in China for treating COVID-19.
  • To verify the scientific basis of CHFs in combating COVID-19 based on existing literature.

Main Methods:

  • Literature review of reported studies on CHFs and their application in viral infections.
  • Analysis of national and provincial-level recommended patent drugs in China for COVID-19 treatment.
  • Synthesis of information on the pharmacological actions and therapeutic mechanisms of CHFs.

Main Results:

  • COVID-19 shares genomic and pathogenic similarities with SARS-CoV and MERS-CoV, suggesting historical treatment strategies may be relevant.
  • Traditional Chinese medicine, including CHFs, is considered a viable option for COVID-19 treatment, either independently or adjunctively.
  • Existing literature and national recommendations suggest potential therapeutic benefits of specific CHFs against COVID-19.

Conclusions:

  • CHFs possess potential therapeutic value in managing COVID-19 progression and symptoms.
  • Historical experience and holistic pharmacological actions support the use of TCM in viral infections.
  • Further high-tech and translational research, including clinical studies, is crucial to validate the efficacy of CHFs for COVID-19.

Related Concept Videos